[go: up one dir, main page]

GB201306147D0 - Novel biomarker signature and uses thereof - Google Patents

Novel biomarker signature and uses thereof

Info

Publication number
GB201306147D0
GB201306147D0 GBGB1306147.8A GB201306147A GB201306147D0 GB 201306147 D0 GB201306147 D0 GB 201306147D0 GB 201306147 A GB201306147 A GB 201306147A GB 201306147 D0 GB201306147 D0 GB 201306147D0
Authority
GB
United Kingdom
Prior art keywords
biomarker signature
novel biomarker
novel
signature
biomarker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1306147.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HA IL, University of
Original Assignee
HA IL, University of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HA IL, University of filed Critical HA IL, University of
Priority to GBGB1306147.8A priority Critical patent/GB201306147D0/en
Publication of GB201306147D0 publication Critical patent/GB201306147D0/en
Priority to PCT/EP2014/056879 priority patent/WO2014162008A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G01N33/57505—
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB1306147.8A 2013-04-05 2013-04-05 Novel biomarker signature and uses thereof Ceased GB201306147D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1306147.8A GB201306147D0 (en) 2013-04-05 2013-04-05 Novel biomarker signature and uses thereof
PCT/EP2014/056879 WO2014162008A2 (en) 2013-04-05 2014-04-04 Novel biomarker signature and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1306147.8A GB201306147D0 (en) 2013-04-05 2013-04-05 Novel biomarker signature and uses thereof

Publications (1)

Publication Number Publication Date
GB201306147D0 true GB201306147D0 (en) 2013-05-22

Family

ID=48483371

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1306147.8A Ceased GB201306147D0 (en) 2013-04-05 2013-04-05 Novel biomarker signature and uses thereof

Country Status (2)

Country Link
GB (1) GB201306147D0 (en)
WO (1) WO2014162008A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016141375A1 (en) * 2015-03-05 2016-09-09 Case Western Reserve University Her2-regulated rna as diagnostic and therapeutic targets in her2-positive breast cancer
CN107217105B (en) * 2017-07-27 2020-10-20 江苏省原子医学研究所 Cancer combined diagnosis marker and application thereof
EP3578981B1 (en) * 2018-06-06 2021-10-27 TUDAG TU Dresden Aktiengesellschaft Anti-cancer treatment of preselected subjects and screening methods to identify susceptible subjects
RU2688313C1 (en) * 2018-10-02 2019-05-21 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации Method for prediction of infertility after risk-adapted treatment of hodgkin lymphoma in children and adolescents
CN111235269A (en) * 2018-11-28 2020-06-05 中国科学院大连化学物理研究所 Application and kit of PLIN2 and reagents for quantitative detection of PLIN2
CN111228289A (en) * 2018-11-28 2020-06-05 中国科学院大连化学物理研究所 Application of PLIN2 inhibitor and medicine mixture for treating tumor
CN114222825A (en) * 2019-07-05 2022-03-22 英特莱克森有限责任公司 Method for diagnosing the effectiveness of an anti-tumor therapy
EP3909600A1 (en) 2020-05-12 2021-11-17 International Centre For Genetic Engineering And Biotechnology - ICGEB Emid2 protein as anti-cancer treatment
EP4443162A1 (en) * 2023-04-03 2024-10-09 Fundación Para La Investigación Biomédica Del Hospital Clínico San Carlos Genetic signature for predicting the response to immunotherapies in a subject
CN119932197B (en) * 2025-04-09 2025-06-13 广州市第一人民医院（广州消化疾病中心、广州医科大学附属市一人民医院、华南理工大学附属第二医院） Application of phosphodiesterase 6D as a biomarker for guiding drug use in prostate cancer
CN121059808B (en) * 2025-11-05 2026-01-30 哈尔滨医科大学 Application of PWWP2B serving as target spot in preparation of leukemia therapeutic drug

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
WO2006135886A2 (en) * 2005-06-13 2006-12-21 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
WO2010118782A1 (en) * 2009-04-17 2010-10-21 Universite Libre De Bruxelles Methods and tools for predicting the efficiency of anthracyclines in cancer

Also Published As

Publication number Publication date
WO2014162008A2 (en) 2014-10-09
WO2014162008A3 (en) 2015-01-08

Similar Documents

Publication Publication Date Title
IL261743B (en) Anti-il-33 antibodies and uses thereof
IL261547B (en) Anti-hepcidin antibodies and uses thereof
IL244510A0 (en) Cancer biomarkers and uses thereof
IL245040B (en) Anti-pdgfr-beta antibodies and uses thereof
IL243974B (en) Anti-prlr antibodies and uses thereof
SG10201708143QA (en) Anti-c10orf54 antibodies and uses thereof
SG11201510282PA (en) Sepsis biomarkers and uses thereof
GB201306147D0 (en) Novel biomarker signature and uses thereof
GB201321474D0 (en) Novel biomarkers
GB201316524D0 (en) Biomarkers
GB201309426D0 (en) Biomarkers
GB201307989D0 (en) Novel combinations and use
ZA201601880B (en) Hetero-transglycosylase and uses thereof
GB201211158D0 (en) Biomarkers and uses thereof
GB201320992D0 (en) Complex and uses thereof
GB201316526D0 (en) Biomarkers
GB201308077D0 (en) Biomarkers
GB201312638D0 (en) Biomarkers
GB201304460D0 (en) Biomarker
GB201322783D0 (en) Biomarkers
GB201308518D0 (en) Novel Biomarker
GB201308639D0 (en) Biomarkers and uses of thereof
GB201313342D0 (en) Biomarkers
GB201218438D0 (en) Biomarkers and uses thereof
GB201301393D0 (en) Kiddibidet and pottibidet

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)